Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early treatment with evolocumab in patients with ST-elevation myocardial infarction
2018-001065-17Phase 2Terminated
- Sponsor
- IRCCS San Matteo Foundation
- Start
- May 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of evolocumab in myocardial infarction (MI), sponsored by IRCCS San Matteo Foundation. Started May 2020; status: terminated.
02
Drugs
evolocumab
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2018-001065-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001065-17.